DUBLIN and BRIDGEWATER, N.J. - Amarin Corporation plc (NASDAQ:AMRN) announced today that it will present new in vitro data on its cardiovascular drug at the upcoming American College of Cardiology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback